Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

The 15 Year Long-Term Survival of Patients with Chronic Myeloid Leukaemia from 35 Regions of Russian Federation: A Follow up of a Multicenter Observation Study Eutos Osp Initiated By European Leukemia NET

Blood (2021) 138 (Supplement 1): 5035.

https://doi.org/10.1182/blood-2021-151371

Published: 2021

Journal Articles

Social Parameters Are Independent Predictors for Survival in Chronic Myeloid Leukemia

Sergei M. Kulikov, PhD, Anna G Turkina, Prof., MD, Anton Kulikovsky, Olga Lazareva, PhD, Sergey Kutsev, Prof., MD, PhD, Elza Lomaia, MD, Andrey Zaritskey, MD PhD, Anatoly Golenkov, MDProf, Tatiana Pospelova, MD PhD, Satokhin Yuri, MD PhD, Tatiana Konstantinova, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2018) 132 (Supplement 1): 1735.

https://doi.org/10.1182/blood-2018-99-114700

Published: 2018

Journal Articles

Dynamics of Gene Expression of Surface Receptors of Apoptosis in Primary Patients with B-CLL during Induction Treatment

Sergei Zakharov, Anatoly Golenkov, MDProf, Vsevolod A. Misyurin, PhD, Elena Kataeva, MD, Andrey Misyurin, PhD, Tatiana Mitina, MD, Baryshnikova Maria, PhD, Elena Trifonova, MD PhD, Yulia Chernykh, Ludmila Vysotskaya, PhD, Elena Klinushkina, Anna G Turkina, Prof., MD, Kirill Belousov

Blood (2017) 130 (Supplement 1): 4970.

https://doi.org/10.1182/blood.V130.Suppl_1.4970.4970

Published: 2017

Journal Articles

Is Quality of Life (QOL) Predictive for Clinical Response in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients Treated with Dasatinib?

Tatiana Ionova, DSc, Natalia Bulieva, MD, Anatoly Golenkov, MDProf, Taras Gritsenko, MD, Lilia Kozlova, MD Prof, Galina Kuchma, MD PhD, Elza Lomaia, MD, Elena Machulaytene, MD, Tatiana Nikitina, PhD, Natalia Novitskaya, MD PhD, Elena Usacheva, MD PhD, Tatiana Shneider, MD, Elena Trifonova, MD PhD, Olga Vinogradova, MD PhD, Anna Zinkovskaya

Blood (2017) 130 (Supplement 1): 2181.

https://doi.org/10.1182/blood.V130.Suppl_1.2181.2181

Published: 2017

Journal Articles

Features of the Immunophenotype of Tumor Plasmocytes in the Bone Marrow and Peripheral Blood for Multiple Myeloma Complicated By Plasmacytomas

Kirill Belousov, Anatoly Golenkov, MD, Tatiana Mitina, Yulia Chuksina, Elena Trifonova, MD PhD, Elena Kataeva, MD, Lyudmila Vysotskaya, Yulia Chernykh, Sergei Zakharov, Aleksandr Mitin, Sergei Shevelev, Yulia Sverkunova, Elena Klinushkina

Blood (2017) 130 (Supplement 1): 5334.

https://doi.org/10.1182/blood.V130.Suppl_1.5334.5334

Published: 2017

Journal Articles

The Analysis of 12-Year Overall Survival in Non-Selected Patients with Chronic Myeloid Leukemia with Tyrosinekinase Inhibitors Therapy in Routine Practice

Lyudmila Vysotskaya, Tatiana Mitina, Elena Trifonova, MD PhD, Yulia Chernykh, Sergei Zakharov, Kirill Belousov, Elena Klinushkina, Elena Kataeva, MD, Anna G Turkina, Prof., MD, Anatoly Golenkov, MDProf

Blood (2017) 130 (Supplement 1): 5261.

https://doi.org/10.1182/blood.V130.Suppl_1.5261.5261

Published: 2017

Journal Articles

Effect of Expression of Multidrug Resistance Genes in Newly Diagnosed Multiple Myeloma on the Clinical Course of the Disease

Yulia Chernykh, Anatoly Golenkov, MD, Lyudmila Vysotskaya, Sain Shushanov, Ekaterina Rybalkina

Blood (2016) 128 (22): 5144.

https://doi.org/10.1182/blood.V128.22.5144.5144

Published: 2016

Journal Articles

Effect of Expression of Multidrug Resistance Genes on Efficacy the Treatment of Multiple Myeloma By Proteasome Inhibitor

Yulia Chernykh, Anatoly Golenkov, MD

Blood (2015) 126 (23): 4859.

https://doi.org/10.1182/blood.V126.23.4859.4859

Published: 2015

Journal Articles

Russian Registry of Chronic Myeloid Leukemia Management in Routine Clinical Practice-Local Therapy and Monitoring

Anna Turkina, Prof., MD, Anatoly Golenkov, MD, Lyudmila Napso, Irina Krylova, Tatiana Klitochenko, Olga Senderova

Blood (2015) 126 (23): 5156.

https://doi.org/10.1182/blood.V126.23.5156.5156

Published: 2015

Journal Articles

Value Research of T-Regs Cells in Peripheral Blood of Patients with Multiple Myeloma

Anatoly Golenkov, MD, Tatyana Mitina, PhD, Yuliya Chernykh, Tatyana Lutskaya, PhD, Alexandr Mitin, PhD, Marina Litvina

Blood (2014) 124 (21): 5697.

https://doi.org/10.1182/blood.V124.21.5697.5697

Published: 2014

Journal Articles

Evaluation of Azacitidine Clinical Efficacy in Patients with Myelodysplasia Syndrome Dudina G.a., Golenkov a.K., Kataeva E.V., Mitina T.a. Moscow Regional Clinical Research Institute

Anatoly Golenkov, MD

Blood (2014) 124 (21): 5625.

https://doi.org/10.1182/blood.V124.21.5625.5625

Published: 2014

Journal Articles

Efficacy Of Bendamustine and Rituximab In Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

Elena Kataeva, MD, Anatoly Golenkov, MD, PhD, Elena Triphonova, Galina Dudina, Tatyana Mitina, Tatyana Lutskaya, Ludmila Vysotskaya, Yulliya Chernykh, Sergey Zakharov

Blood (2013) 122 (21): 5312.

https://doi.org/10.1182/blood.V122.21.5312.5312

Published: 2013

Journal Articles

Results of Tyrosine Kinase Inhibitors (TKI) Therapy of Patients (Pts) with Chronic Myeloid Leukemia (CML) In Clinical Practice Analysed In the Frame of International Research Project EUTOS In Russian Federation

Anna G. Turkina, MD, PhD, Sergey Kulikov, Kudrat Abdulkadirov, Sergey Kutsev, MD, PhD, Anatoly Golenkov, MD, Valentina Ivanova, Tatiana Pospelova, MD, PhD, Tatiana Konstantinova, Olga Lazareva, PhD, Nina Khoroshko, MD, PhD

Blood (2011) 118 (21): 4447.

https://doi.org/10.1182/blood.V118.21.4447.4447

Published: 2011

Journal Articles

Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone

Jean-Luc Harousseau, Antonio Palumbo, Paul G. Richardson, Rudolf Schlag, Meletios A. Dimopoulos, Ofer Shpilberg, Martin Kropff, Alain Kentos, Michele Cavo, Anatoly Golenkov, Mieczyslaw Komarnicki, Maria-Victoria Mateos, Dixie-Lee Esseltine, Andrew Cakana, Kevin Liu, William Deraedt, Helgi van de Velde, Jesús F. San Miguel

Blood (2010) 116 (19): 3743–3750.

https://doi.org/10.1182/blood-2010-03-275800

Published: 2010

Includes: Supplemental data

Journal Articles

The Alemtuzumab Treatment of Refractory to Fludarabine Chronic Lymphocytic Leukemia Patients.

Elena Kataeva, MD, Anatoly Golenkov, Ph.D., Elena Triphonova, Iolanta Buravtsova, M.D.

Blood (2009) 114 (22): 4415.

https://doi.org/10.1182/blood.V114.22.4415.4415

Published: 2009

Journal Articles

Superior Outcomes Associated with Complete Response: Analysis of the Phase III VISTA Study of Bortezomib Plus Melphalan–Prednisone Versus Melphalan–Prednisone

Jean-Luc Harousseau, Antonio Palumbo, Paul Richardson, Rudolf Schlag, Meletios A Dimopoulos, Ofer Shpilberg, Martin H Kropff, Michel Delforge, Rik Schots, Michele Cavo, Anatoly Golenkov, Mieczyslaw Komarnicki, Maria-Victoria Mateos, Andrew Cakana, Kevin Liu, William Deraedt, Helgi van de Velde, Jesus F San Miguel

Blood (2008) 112 (11): 2778.

https://doi.org/10.1182/blood.V112.11.2778.2778

Published: 2008

Journal Articles

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial

Hagop Kantarjian, Ricardo Pasquini, Nelson Hamerschlak, Philippe Rousselot, Jerzy Holowiecki, Saengsuree Jootar, Tadeusz Robak, Nina Khoroshko, Tamas Masszi, Aleksander Skotnicki, Andrzej Hellmann, Andrey Zaritsky, Anatoly Golenkov, Jerald Radich, Timothy Hughes, Athena Countouriotis, Neil Shah

Blood (2007) 109 (12): 5143–5150.

https://doi.org/10.1182/blood-2006-11-056028

Published: 2007

NARROW

The 15 Year Long-Term Survival of Patients with Chronic Myeloid Leukaemia from 35 Regions of Russian Federation: A Follow up of a Multicenter Observation Study Eutos Osp Initiated By European Leukemia NET

Social Parameters Are Independent Predictors for Survival in Chronic Myeloid Leukemia

Dynamics of Gene Expression of Surface Receptors of Apoptosis in Primary Patients with B-CLL during Induction Treatment

Is Quality of Life (QOL) Predictive for Clinical Response in Chronic Phase-Chronic Myeloid Leukemia (CP-CML) Patients Treated with Dasatinib?

Features of the Immunophenotype of Tumor Plasmocytes in the Bone Marrow and Peripheral Blood for Multiple Myeloma Complicated By Plasmacytomas

The Analysis of 12-Year Overall Survival in Non-Selected Patients with Chronic Myeloid Leukemia with Tyrosinekinase Inhibitors Therapy in Routine Practice

Effect of Expression of Multidrug Resistance Genes in Newly Diagnosed Multiple Myeloma on the Clinical Course of the Disease

Effect of Expression of Multidrug Resistance Genes on Efficacy the Treatment of Multiple Myeloma By Proteasome Inhibitor

Russian Registry of Chronic Myeloid Leukemia Management in Routine Clinical Practice-Local Therapy and Monitoring

Value Research of T-Regs Cells in Peripheral Blood of Patients with Multiple Myeloma

Evaluation of Azacitidine Clinical Efficacy in Patients with Myelodysplasia Syndrome Dudina G.a., Golenkov a.K., Kataeva E.V., Mitina T.a. Moscow Regional Clinical Research Institute

Efficacy Of Bendamustine and Rituximab In Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

Results of Tyrosine Kinase Inhibitors (TKI) Therapy of Patients (Pts) with Chronic Myeloid Leukemia (CML) In Clinical Practice Analysed In the Frame of International Research Project EUTOS In Russian Federation

Superior outcomes associated with complete response in newly diagnosed multiple myeloma patients treated with nonintensive therapy: analysis of the phase 3 VISTA study of bortezomib plus melphalan-prednisone versus melphalan-prednisone

The Alemtuzumab Treatment of Refractory to Fludarabine Chronic Lymphocytic Leukemia Patients.

Superior Outcomes Associated with Complete Response: Analysis of the Phase III VISTA Study of Bortezomib Plus Melphalan–Prednisone Versus Melphalan–Prednisone

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only